These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34408607)

  • 1. Preclinical meritorious anticancer effects of Metformin against breast cancer: An
    Rizvi F; Shaukat L; Azhar A; Jafri A; Aslam U; Imran-Ul-Haq H
    J Taibah Univ Med Sci; 2021 Aug; 16(4):504-512. PubMed ID: 34408607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuating tumour angiogenesis: a preventive role of metformin against breast cancer.
    Gao S; Jiang J; Li P; Song H; Wang W; Li C; Kong D
    Biomed Res Int; 2015; 2015():592523. PubMed ID: 25883966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPEG-PCL Nanomicelles Platform for Synergistic Metformin and Chrysin Delivery to Breast Cancer in Mice.
    Luo D; Wang X; Zhong X; Chang J; He M; Wang H; Li Y; Zhao C; Luo Y; Ran L
    Anticancer Agents Med Chem; 2022; 22(2):280-293. PubMed ID: 34165412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crocin and Metformin suppress metastatic breast cancer progression via VEGF and MMP9 downregulations: in vitro and in vivo studies.
    Farahi A; Abedini MR; Javdani H; Arzi L; Chamani E; Farhoudi R; Talebloo N; Hoshyar R
    Mol Cell Biochem; 2021 Sep; 476(9):3341-3351. PubMed ID: 33929675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours.
    Cai H; Everett RS; Thakker DR
    Br J Pharmacol; 2019 Aug; 176(15):2724-2735. PubMed ID: 31032880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
    Burade V; Bhowmick S; Maiti K; Zalawadia R; Ruan H; Thennati R
    BMC Cancer; 2017 Jun; 17(1):405. PubMed ID: 28587612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer.
    Fan C; Wang Y; Liu Z; Sun Y; Wang X; Wei G; Wei J
    Int J Mol Med; 2015 Jul; 36(1):204-14. PubMed ID: 25999130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression.
    Zhang J; Li G; Chen Y; Fang L; Guan C; Bai F; Ma M; Lyu J; Meng QH
    J Cancer; 2017; 8(10):1849-1864. PubMed ID: 28819383
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
    Phoenix KN; Vumbaca F; Claffey KP
    Breast Cancer Res Treat; 2009 Jan; 113(1):101-11. PubMed ID: 18256928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes.
    Vakili-Ghartavol R; Mehrabian A; Mirzavi F; Rezayat SM; Mashreghi M; Farhoudi L; Kharrazi S; Sadri K; Jaafari MR
    J Pharm Pharmacol; 2022 Sep; 74(9):1307-1319. PubMed ID: 35833585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis.
    Cauchy F; Mebarki M; Leporq B; Laouirem S; Albuquerque M; Lambert S; Bourgoin P; Soubrane O; Van Beers BE; Faivre S; Bedossa P; Paradis V
    Clin Sci (Lond); 2017 Jan; 131(1):27-36. PubMed ID: 27803295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma.
    Ma J; Guo Y; Chen S; Zhong C; Xue Y; Zhang Y; Lai X; Wei Y; Yu S; Zhang J; Liu W
    BMC Cancer; 2014 Mar; 14():172. PubMed ID: 24612549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma: an experimental study.
    Pateliya B; Burade V; Goswami S
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1949-1961. PubMed ID: 34125254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells.
    Fan Y; Cheng H; Liu Y; Liu S; Lowe S; Li Y; Bentley R; King B; Tuason JPW; Zhou Q; Sun C; Zhang H
    Front Pharmacol; 2022; 13():955984. PubMed ID: 36046821
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study.
    Jang WI; Kim MS; Jeong JH; Kim W; Kim JS
    Anticancer Res; 2022 Feb; 42(2):867-876. PubMed ID: 35093884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
    Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
    Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.
    Cufi S; Corominas-Faja B; Vazquez-Martin A; Oliveras-Ferraros C; Dorca J; Bosch-Barrera J; Martin-Castillo B; Menendez JA
    Oncotarget; 2012 Apr; 3(4):395-8. PubMed ID: 22565037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial.
    Huang J; Tong Y; Hong J; Huang O; Wu J; He J; Chen W; Li Y; Chen X; Shen K
    Breast Cancer Res Treat; 2023 Feb; 197(3):525-533. PubMed ID: 36525180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
    Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumour effect of metformin in canine mammary gland tumour cells.
    Saeki K; Watanabe M; Tsuboi M; Sugano S; Yoshitake R; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
    Vet J; 2015 Aug; 205(2):297-304. PubMed ID: 25981932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.